Abstract
Purpose of Review
Night work is increasingly common and a necessity in certain sectors of the modern 24-h society. The embedded exposure to light-at-night, which suppresses the nocturnal hormone melatonin with oncostatic properties and circadian disruption, i.e., misalignment between internal and external night and between cells and organs, are suggested as main mechanisms involved in carcinogenesis. In 2007, the International Agency for Research on Cancer (IARC) classified shift work that involves circadian disruption as probably carcinogenic to humans based on limited evidence from eight epidemiologic studies on breast cancer, in addition to sufficient evidence from animal experiments. The aim of this review is a critical update of the IARC evaluation, including subsequent and the most recent epidemiologic evidence on breast cancer risk after night work.
Recent Findings
After 2007, in total nine new case-control studies, one case-cohort study, and eight cohort studies are published, which triples the number of studies. Further, two previous cohorts have been updated with extended follow-up. The assessment of night shift work is different in all of the 26 existing studies. There is some evidence that high number of consecutive night shifts has impact on the extent of circadian disruption, and thereby increased breast cancer risk, but this information is missing in almost all cohort studies. This in combination with short-term follow-up of aging cohorts may explain why some cohort studies may have null findings. The more recent case-control studies have contributed interesting results concerning breast cancer subtypes in relation to both menopausal status and different hormonal subtypes. The large differences in definitions of both exposure and outcome may contribute to the observed heterogeneity of results from studies of night work and breast cancer, which overall points in the direction of an increased breast cancer risk, in particular after over 20 years of night shifts.
Summary
Overall, there is a tendency of increased risk of breast cancer either after over 20 years of night shift or after shorter periods with many consecutive shifts. More epidemiologic research using standardized definitions of night work metrics and breast cancer subtypes as well as other cancers is needed in order to improve the epidemiologic evidence in combination with animal models of night work. Also, evidence-based preventive interventions are needed.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Working outside the hours with daylight from about 7 a.m. to 7 p.m. has become increasingly normal during the last 100 years. The invention of electrical lighting and the industrialization of Western countries in the late 1800s have facilitated this change of working life from solely the period with naturally lighted day period to also include evening, night, and early morning by use of artificial electrical light. Consequently, most work has moved from outdoor with bright natural light exposure to indoor with dim light conditions, including a narrower spectrum than natural daylight [1]. Currently, in the EU, about 22% of men and 11% of women work on shifts that include night work. Similarly in the USA, about 17% of full-time salaried men and 12% of women worked on shifts that included nights [2]. The most frequent sectors with night work are hospitals, hotels, transportation, security, and parts of industry that depend on a 24-h production 7 days a week, as well as modern societies in general expect 24-h activity [3, 4]. Shift and night work are complex exposures due to many different aspects that may characterize such exposure, including the direction of shifts (e.g., forwards (day, evening, night) and backwards (day, morning, night)), time of start and end, sequence of non-day shifts, work hours per shift, and rest periods between shifts [5]. Thus, Hall et al. in a recent study from Canada based on a survey of 88 companies observed over 400 different shift-systems [6].
From ancient time, the light on Earth has been determined by the planet’s 24-h rotation about itself (morning, day, evening and night) and about the 365-days circulation around the sun (seasons). Consequently, over the 3 billion years evolutionary past, virtually all life on Earth from cyanobacteria to humans has adapted to the 24 h circle of light and dark. Thus, the timing and duration of the daily exposure to light is known as one of the most important determinants for circadian (24 h) rhythms (daily oscillation) in humans, animals, and other living species on the Earth [7, 8]. In humans and other mammals, the pineal gland hormone melatonin is the main biological signal which synchronizes the main time keeper, the suprachiasmatic nucleus (SCN) in the anterior hypothalamus, with local clocks in cells and tissue, and aligns the entire circadian system to the local environmental dark-light time of the 24-h day [9]. Normally, melatonin is only produced from dusk to dawn, and the amplitude and total daily production is strongly influenced by age, sex, chronotype (morning or evening preference), individual sensitivity, timing, duration, and history and spectrum of light exposure on retina during the day. In the event of exposure to light-at-night, e.g., during social activities or in particular work, melatonin is normally suppressed, and a phase shift may occur after several consecutive light-at-night exposures [10,11,12,13]. Melatonin has oncostatic properties in animal assays and has been shown to mediate pathways involved in cancer [14], including estrogens involved in breast cancer [15, 16]. Further, it has been shown in some prospective studies that women with the highest levels of metabolites of melatonin have a lower risk of breast cancer compared to women with the lowest levels [17, 18].
Three decades ago Richard Stevens was the first to hypothesize that exposure to light-at-night may suppress the pineal gland production of melatonin and in turn increase the risk of breast cancer [19].
In 2007, the International Agency for Research on Cancer (IARC), which is a part of the WHO, evaluated the evidence of shift work in relation to cancer. Due to the normal procedure by IARC, the evidence from epidemiology, animal experiments, and mechanistic studies were evaluated separately, and an overall synthesized conclusion was established [20]. Only eight epidemiologic studies (three cohorts and five case-control studies) on shift work and breast cancer were available for the 2007 evaluation. The strongest evidence came from two independent prospective cohort studies on nurses from the USA, showing significantly increased breast cancer risk after over 20–30 years of rotating night shift work [21, 22]. Additional support came from four case-control studies and several studies on flight attendants with increased breast cancer risk. The latter group may both have had night work and have crossed time zones, but results may at least partly be confounded from exposure to cosmic radiation [4]. A crude meta-analysis based on the longest category of night work exposure from six studies found a relative risk of breast cancer of 1.51 (95% CI, 1.36–1.68) [23]. Overall, the evidence for an association between night work and breast cancer was credible, but bias, confounding, and chance could not be excluded (i.e., limited evidence according to IARC criteria). Over 50 animal experiments were available representing different biological aspects of melatonin and light exposure, including animal “jet lag models,” rather than “shift work models.” In particular, Blask et al. conducted a novel experiment where nocturnal light exposure was shown to decrease melatonin levels and to progress the growth of human breast cancer cells in rat models [24, 25]. Overall, there was sufficient evidence in experimental animals for the carcinogenicity of light during the daily dark period (biological night). Furthermore, experimental data supported that similar biological mechanisms occur both in animals and humans on molecular, cellular, and systemic level [26]. Taking all the evidence together, it was concluded that shift work that includes circadian disruption is probably carcinogenic to humans [27]. Subsequently, it became possible in Denmark as the only country so far to get breast cancer after long-term night shift work acknowledged as an occupational disease and get economical compensation [28].
The 2007 evaluation by IARC apparently stimulated epidemiologic research on shift work and cancer. Although there have been some studies on shift work and other cancer sites than breast cancer, in particular prostate and colorectal cancers, relatively few studies have addressed these cancers compared to breast cancer. Therefore, an overall evaluation of other cancers than breast cancer is somewhat in its early phase due to the lack of epidemiological studies.
The main aim of the present review is to describe and evaluate studies on night work and risk of breast cancer that have been published since the IARC evaluation in 2007.
Assessment of the Night Shift Work Exposure
Accurate assessment of exposure is normally the Achilles’ heel in all epidemiologic studies and inaccurate exposure may bias results. All studies on shift and night work and breast cancer risk have used different definitions of the exposure, and partly adjusted for different potential confounders, which was one of the limitations of the epidemiological studies noted at the 2007 IARC evaluation [2]. Therefore, an international group of epidemiologists gathered for a workshop at IARC in 2009 and suggested standardization of variables used in future studies [29]. In particular, it was suggested that studies should capture at least “1) shift system (start time of shift, number of hours per day, rotating or permanent, speed and direction of a rotating system, regular or irregular); 2) years on a particular non-day shift schedule (cumulative exposure to the shift system over the subject’s working life); and 3) shift intensity (time off between successive work days on the shift schedule)” [29]. Despite these recommendations, all of the recent studies on night work and cancer have used different definitions of night work concerning both the period of work within the 24-h day and the intensity of night work, i.e., consecutive working nights and periods of rest in between. Thus, many studies, including all existing cohorts use only number of years of night shift as a surrogate for dose, irrespectively that most persons do not have night work every day of the year. This inaccurate assessment of the extent of night work may underestimate risks because of the obvious different impact, within the span from a few to 31 nights per month, on physiology and thereby potentially the breast cancer risk. One exception is a large register-based cohort from Denmark based on all employees in public hospitals where objective payroll data, including time of start and end of each shift, is available from 2007 to 2012 on an individual level [30]. Because of the potential for linkage with many health-related registries in Denmark [31], this cohort will be very valuable in future decades when sufficient follow-up time for cancer becomes available.
The intention in most definitions of night work that are used in epidemiological studies of cancer is to focus on exposure to electrical light during the period of the night where melatonin normally peeks, i.e., during about 2–3 a.m. [32, 33]. A recent study, including employees mainly at hospitals showed that the proportion of shifts classified as night shifts in practice differs little in Denmark when night shifts are based on definitions including a period during the night (i.e., working time after midnight) [30]. Thus, the critical issue concerning definition of night shifts may rather be the number of consecutive night shift, e.g., during a week, which have different physiological impact on circadian disruption and cancer risk [34,35,36].
Differences in exposures to intensity and wavelength of the light, which may be very different in different occupational settings, also influence the level of melatonin suppression during the night [37, 38••]. Furthermore, individual differences in diurnal preference, which seems partly under genetic influence, result in melatonin peaking earlier for people with morning preference and later than average for people with evening preference [39,40,41,42,43,44]. Thus, the genetic component of diurnal preference or chronotype seems associated with breast cancer risk [32] via a polymorphism in the circadian gene PER3 [45] [46]. One relatively small case-control study has shown that both women with morning and evening preference have an increased risk of breast cancer associated with night shift work, but the risk is highest for women with morning preference [47]. This has, however, yet to be confirmed in larger studies.
Information on working time is normally obtained by self-reports from study participants, which potentially may be inaccurately obtained by questionnaires or interviews both in cohort and in case-control studies. Härmä et al. has recently compared objective information on working time from payroll data with questionnaire-based data on working time. Overall, there was a good correlation between self-reported shift work with night work, and permanent night shift (sensitivity and specificity over 90%), whereas shift work without night work had moderate validity (sensitivity 62%; specificity 87%). If this can be generalized to other studies, this means that self-reported information on night work in general may be valid, but may underestimate the effects in shift work without night shifts [48].
New Epidemiologic Evidence After the 2007 IARC Evaluation
In total, nine case-control studies [47, 49,50,51,52,53,54,55,56], one case-cohort study [57], and eight cohort studies have been published since the IARC evaluation [58,59,60,61,62,63]. Results and descriptive characteristics of the 18 new studies are shown in Tables 1 and 2. Including the eight studies available at the IARC evaluation [21, 22, 64,65,66,67,68,69], in total, 26 studies of night shift work and breast cancer were published in scientific journals by the end of 2016. A recent update, including 14 years of extended follow-up of two independent studies based on Nurses Health cohorts [21, 22] originally issued in 2001 and 2006, were published in early 2017 [70••].
Cohort Studies
All of the existing cohort studies, including those published prior to the 2007 IARC evaluation, were designed for other purposes than studying the association between night work and breast cancer. Thus, information on night work in all these studies is limited to relatively crude and imprecise questions on night work, which most often have been obtained several years after the establishment of the cohorts. Thus, at its best, they have information on duration of night work, but not on intensity, e.g., number of shifts during a week or month. Typically, the main shift work related question is “How many years have you worked during the night?”
Many cohort studies [21, 22, 59, 61, 70••], even without information on night shift intensity, have shown increased breast cancer risk, however, only after long-term night work.
In contrast, a recent series of three large UK cohorts on night work and breast cancer found no association [62]. The main limitations in the UK cohorts are short follow-up time (3 years) and an aging survivor population (68 years old at baseline) where women may have stopped working years before start of follow-up and consequently may be negatively biased due to severe left-truncation [71,72,73,74,75]. Thus, it has recently been shown from the large American Nurses’ Health Study (baseline 1988) that the risk of breast cancer attenuates and disappears years after cessation of night shifts. Thus, an estimated relative risk of 1.36 (95% CI, 1.07–1.78) among the nurses with at least 30 years rotation night work (mean age 60 years old at baseline) changed to a relative risk of 0.95 (95% CI, 0.77–1.17) when follow-up was continued from 1998 to 2012, thus including only nurses with post-retirement time [21, 70]. In contrast, the increased relative risk for nurses with at least 20 years of night shift work in the equivalent 19 years old younger cohort of Nurses’ Health study II (41 years old at baseline in 1989) remained increased after the similar extended follow-up period (relative risk of 2.15 (95% C.I, 1.23–3.73)). Another recent study is based on payroll information from primary hospital employees in Denmark, where females are followed up for breast cancer during 2008–2012, i.e., for a maximum of 5 years [63]. There was no evidence of an association between cumulative night shift work and breast cancer risk in this study. In addition to the relatively short follow-up time, the major limitation of this study is lack of information on working time prior to 2007, because it is highly likely that the reference group of dayworkers in the period after 2007 have been exposed to night work at earlier ages before 2007 [76], since virtually all health professionals in Denmark have night work early in their career. Null results have also been found in one cohort with crude exposure assessment [60] based on Dutch Labor Force Surveys, which did not even have information on duration of night work [60]. Also a relative large cohort from Shanghai, China (mean age 53 years old at baseline in 1996–2000) reported null results [58], both based on applying a job exposure matrix at baseline and based on questionnaires on night work obtained during 2002–2004. Cohort members were followed up for breast cancer until the end of 2007, thus, only between 3 and maximum 7 years for the sub-cohort, including self-reported night work information, which limits the statistical power of the study, including only 73 women with night work and breast cancer. Further, it has been suggested that Asian ethnicity like the Chinese is less prone to circadian disturbance [77, 78]. Finally, in contrast, two independent cohorts from Sweden that included younger participants than the null studies and have longer follow-up time reported increased relative risks for long-term night shift workers [59, 61].
Case-Control Studies
As shown in Table 2, most case-control studies observe increased relative risks for breast cancer, though they are not all significantly increased [47, 49, 50, 52,53,54, 64,65,66,67, 79, 80].
A case-control study on nurses from Denmark attempted to differentiate between associations of breast cancer and evening shifts, rotating night shifts, and permanent night shifts, i.e., normal consecutive night work, respectively [80]. Results from this study indicates no association with breast cancer and evening shifts from 3 p.m. to 11 p.m. (OR = 0.9; 95% CI 0.4–1.9), but increased risk for both rotating (OR = 1.8; 1.2–2.8) and permanent night shifts from 11 p.m. to 7 p.m. (OR = 2.9; 95% CI 1.1–8.0). This was partly replicated in a study from Spain where the category of over 1800 permanent night shifts, indicated higher OR than the similar number of rotating night shifts, 1.48; 95% CI 0.81–2.68 versus OR = 1.08; 95% CI 0.66–1.79 [55].
It has been suggested that circadian disruption and misalignment of internal clocks normally occurs only after over three consecutive night shifts [26, 34]. Two case-control studies from Norway and Denmark have focused on the importance of number of consecutive night shifts and association with breast cancer risk in nurses and find only increased risk after at least 3–4 consecutive night shifts during at least 5 years [47, 50]. This was, however, not replicated in a more recent study from France [52].
The French study hypothesized that the risk of breast cancer should be more pronounced if night work starts before the first pregnancy, when mammary gland cells are incompletely differentiated than after first full-term pregnancy. Interestingly, the relative risk for these two situations were 1.47 (95% CI 1.02–2.12) and 1.09 (95% CI 0.77–1.55), respectively [52].
Subtypes of Breast Cancer
Despite the fact that breast cancer is a group of heterogeneous diseases, it has been treated as one entity in most, but not all studies on night work. This may also have contributed to the heterogeneity in results unless night work is associated with all subtypes, which is less likely. Different ages of study participant’s that have different distributions of pre- and postmenopausal breast cancers have been suggested to have potential different etiology [81], thus may influence results on studies of night work and breast cancer. A recent study using pooled data from five case-control studies showed that it is in particular premenopausal breast cancer is increased after night work, rather than postmenopausal breast cancer [49, 52,53,54, 79, 82]. The same findings were seen in a recent study from China [56], and in the updated Nurse’s Health studies [70••]. It can be generalized that this may further contribute to explain the heterogeneity in results of studies of night work and cancer where the age distribution and menopausal status is diverse. In particular, the recent negative UK cohorts consist in particular of women, who are almost all postmenopausal [62].
The distribution of different hormonal subtypes in breast cancer may also influence results [83, 84]. This has been studied in a number of case-control studies and in a case-control study nested within cohorts, where some heterogeneity in results has been observed [21, 53, 55, 56, 63, 85,86,87]. The most consistent findings is between night work and the human epidermal growth factor positive (HER2+) breast cancers [55, 56, 63, 86], which also has shown to be associated with melatonin suppression in experimental studies [88]. Thus, four such recent studies showed OR’s in the range of 1.3–1.9, though results were only significant in one study from France [86].
Meta-analyses
Meta-analysis is a useful tool in order to make overall risk estimates of existing studies. A main requirement for conducting such analyses is, however, the existence of similar definitions of both exposure and outcome in included studies, which is not the case for any of the existing studies on night work and breast cancer [89]. Further, different criteria have been used for inclusion and exclusion of studies and each meta-analysis is thereby subject to different lists of studies. For instance, the most recent meta-analysis by Travis et al., which despite violation of normal criteria for conduction proper meta-analysis found no association when they included their own studies, was solely based on cohort studies [62], and did not include the most recent update of Nurses’ Health studies [70••]. Overall, a number of recent meta-analyses have been published from authors without previous research within this field, and with somewhat different results and conclusions [62, 90,91,92,93].
General Limitations and Confounding
In industrialized societies, most people suffer from some circadian disruption originating from social obligations, so called social jet lag. Thus, most people normally delay bedtime and advance their wake up time, which is then often compensated during the days off [94]. In a population-based study in Germany, the average level of social jet lag was about 1.5 h [95]. This means that even a group of dayworkers is not fully appropriate as a “clean” reference group, which is ideally required in epidemiologic studies, which may dilute a true increased risk from night work, if such an association exists. In the majority of studies, adjustment for potential confounders seems without major influence. If any, the confounding seems mostly weakly negative (data not shown).
In general, the more recent case-control studies have a more detailed assessment of working time in comparison with both previous cases-control studies and most of the existing cohort studies. Almost all of the case-control studies were designed with the main purpose of investigating night work and breast cancer risk. Thus, most case-control studies have information on both duration of night work and intensity, e.g., number of lifetime shifts (Table 2). Furthermore, the case-control studies have normally obtained lifetime history of working time, job-by-job for a broad range of ages, whereas cohort studies often are prone to left-truncation bias because the age at baseline of disease-free cohort members is usually relatively high in order to capture as many cases in the near future. This is particularly problematic for studies of working time because complex mechanisms of selection in and out of night work exist, which may be better captured in case-control studies than in prospective cohort studies. On the other hand, case-control studies may be subject to recall and participation bias. Therefore, evidence based on results from different well-conducted study designs is also needed in the future.
New Study Directions
Animal models included in the IARC 2007 focused on the effect of ill-timed exposure to light and aspects of melatonin, including pinealectomy. Van Dycke et al. has recently reported on an animal model of rotating shift work where a group of control mice where one group of mice were exposed to 12 h of light and 12 h of darkness circles over about 70 weeks. Another group had the same cycle of exposure to light and darkness, but each week, the period of light and darkness was reversed. Almost all mice in both groups developed breast cancer. However, the group of mice that were exposed to simulated rotating night work had a significantly decreased latency of breast cancer of about 8 weeks compared to the control group [96•]. Timing and quality of meals in shift workers is significantly different from dayworkers, and breast cancer risk is a new avenue of research which should be included in future studies [97,98,99]. Moreover, some pioneering results concerning long-term night work and epigenetic changes should be explored further [16, 100].
Prevention
Although night work yet remains to be confirmed as a cause of breast cancer, initiatives for preventive actions may be prudent [101]. In 2012, an international group suggested a few guidelines in order to prevent potential breast cancer after night work, especially by using only forward rotating shifts, limiting the period with night shift work and by limiting the number of consecutive night shifts [102]. In general, however, there is a lack of evidence-based studies on this topic, in particular concerning night work and potential health outcomes in general [103]. Thus, future in-depth understanding of mechanisms may improve evidence-based prevention [104].
Conclusion
The number of new studies on night work and breast cancer has increased over threefold during the last 10 years after the IARC evaluation in 2007. In general, the case-control studies are better in capturing at least some of the complexity of night shift work, including intensity of night work than the cohort studies. Further, all recent studies include information on most potential confounders for breast cancers, although confounding appears to be relatively low, and in most studies in a negative direction. Four recent cohort studies from the UK and Denmark, despite advances in relatively large study populations, have not provided evidence of an association between night work and breast cancer risk. These null findings may be due to limitations in the design of these studies. Overall, the observed heterogeneity in results from epidemiologic studies may at least partly be attributed to wide differences in the definitions of night work, study design, length of follow-up, left-truncation in cohort studies, lack of information on chronotype, social jet lag, and differences in the investigated populations’ menopausal status and breast cancer subtypes. Future studies on night work and cancer should use standardized definition of working time, including information on number of consecutive shifts, diurnal preference, menopausal status, and meal intake patterns. Cohort studies should include lengthy follow-up of relative young people. Overall, evidence based on results from different well-conducted study designs is also needed in the future. Finally, there is a need for studies of sites of other cancers than breast cancer.
Overall, the epidemiological evidence of an association between shift work that includes night work has increased since the IARC evaluation in 2007, and it might soon be time for a reevaluation by IARC.
References
Papers of particular importance, published recently, have been highlighted as: • Of importance •• Of major importance
Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 2001;12(3):279–87.
Costa G, Haus E, Stevens R. Shift work and cancer— considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health. 2010;36(2):163–79. doi:2899 [pii]
Rajaratnam SM, Arendt J. Health in a 24-h society. Lancet. 2001;358(9286):999–1005.
Cancer IAfRo. Painting, firefighting, and shiftwork. IARC Monogr Eval Carcinog Risks Hum. 2010;98:9–764.
Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, et al. Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC working group report. Occup Environ Med. 2011;68(2):154–62. doi:10.1136/oem.2009.053512.
Hall AL, Smit AN, Mistlberger RE, Landry GJ, Koehoorn M. Organisational characteristics associated with shift work practices and potential opportunities for intervention: findings from a Canadian study. Occup Environ Med. 2017;74(1):6–13. doi:10.1136/oemed-2016-103664.
Gerhart-Hines Z, Lazar MA. Circadian metabolism in the light of evolution. Endocr Rev. 2015;36(3):289–304. doi:10.1210/er.2015-1007.
Stevens RG. Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world. Mutat Res. 2009;680(1–2):106–8.
Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR. Melatonin—a pleiotropic, orchestrating regulator molecule. Prog Neurobiol. 2011;93(3):350–84. doi:10.1016/j.pneurobio.2010.12.004.
Lucas RJ, Peirson SN, Berson DM, Brown TM, Cooper HM, Czeisler CA, et al. Measuring and using light in the melanopsin age. Trends Neurosci. 2014;37(1):1–9. doi:10.1016/j.tins.2013.10.004.
Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res. 2010;181:127–51.
Kandalepas PC, Mitchell JW, Gillette MU. Melatonin signal transduction pathways require E-box-mediated transcription of Per1 and Per2 to reset the SCN clock at dusk. PLoS One. 2016;11(6):e0157824. doi:10.1371/journal.pone.0157824.
Chang AM, Scheer FA, Czeisler CA. The human circadian system adapts to prior photic history. J Physiol. 2011;
Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther. 2009;8(4):337–46.
Hill SM, Belancio VP, Dauchy RT, Xiang S, Brimer S, Mao L, et al. Melatonin: an inhibitor of breast cancer. Endocr Relat Cancer. 2015;22(3):R183–204. doi:10.1530/ERC-15-0030.
Bracci M, Manzella N, Copertaro A, Staffolani S, Strafella E, Barbaresi M, et al. Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-beta-estradiol levels. Scand J Work Environ Health. 2014;40(3):295–304. doi:10.5271/sjweh.3414.
Devore EE, Warner ET, Eliassen H, Brown SB, Beck AH, Hankinson S, et al. Urinary melatonin in relation to postmenopausal breast cancer risk according to melatonin 1 receptor status. Cancer Epidemiol Biomark Prev. 2016; doi:10.1158/1055-9965.EPI-16-0630.
Basler M, Jetter A, Fink D, Seifert B, Kullak-Ublick GA, Trojan A. Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care (Basel). 2014;9(3):182–7. doi:10.1159/000363426.
Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol. 1987;125(4):556–61.
Cancer IAfRo. Preample. Lyon2006 2006.
Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst. 2001;93(20):1563–8.
Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17(1):108–11.
Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005;41(13):2023–32. doi:10.1016/j.ejca.2005.05.010.
Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC. Light during darkness, melatonin suppression and cancer progression. !Lost Data. 2002;23(Suppl 2):52–6.
Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 2005;65(23):11174–84.
Haus E, Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control. 2006;17(4):489–500.
Straif K, Silverstein M. Comparison of U.S. Occupational Safety and Health Administration standards and German Berufsgenossenschaften Guidelines for Preventive Occupational Health Examinations. Am J Ind Med. 1997;31(4):373–80. doi:10.1002/(SICI)1097-0274(199704)31:4<373::AID-AJIM1>3.0.CO;2-X. [pii]
Hansen J. Women with night shift work and breast cancer: the situation in Denmark. J Epidemiol Community Health. 2010;64(12):1025–6. doi:10.1136/jech.2009.101691.
Stevens RG. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol. 2009;38(4):963–70. doi:10.1093/ije/dyp178.
Garde AH, Hansen J, Kolstad HA, Larsen AD, Hansen AM. How do different definitions of night shift affect the exposure assessment of night work? Chronobiol Int. 2016;33(6):595–8. doi:10.3109/07420528.2016.1167729.
Frank L. Epidemiology: when an entire country is a cohort. Science. 2000;287(5462):2398–9.
Arendt J. Shift work: coping with the biological clock. Occup Med (Lond). 2010;60(1):10–20.
Arendt J. Melatonin and human rhythms. Chronobiol Int. 2006;23(1–2):21–37.
Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev. 2013;17(4):273–84. doi:10.1016/j.smrv.2012.08.003.
Jensen MA, Garde AH, Kristiansen J, Nabe-Nielsen K, Hansen AM. The effect of the number of consecutive night shifts on diurnal rhythms in cortisol, melatonin and heart rate variability (HRV): a systematic review of field studies. Int Arch Occup Environ Health. 2016;89(4):531–45. doi:10.1007/s00420-015-1093-3.
Jensen MA, Hansen AM, Kristiansen J, Nabe-Nielsen K, Garde AH. Changes in the diurnal rhythms of cortisol, melatonin, and testosterone after 2, 4, and 7 consecutive night shifts in male police officers. Chronobiol Int. 2016:1–13. doi:10.1080/07420528.2016.1212869.
Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Adverse health effects of nighttime lighting: comments on American Medical Association policy statement. Am J Prev Med. 2013;45(3):343–6. doi:10.1016/j.amepre.2013.04.011.
•• Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin. 2014;64(3):207–18. doi:10.3322/caac.21218. The most comprehensive overview of concequences of light-at-night, shift-work, melatonin, circadian disruption on breast cancer risk
Roenneberg T, Hut R, Daan S, Merrow M. Entrainment concepts revisited. J Biol Rhythm. 2010;25(5):329–39.
Roenneberg T, Chua EJ, Bernardo R, Mendoza E. Modelling biological rhythms. Curr Biol. 2008;18(17):R826–R35.
Roenneberg T, Merrow M. Entrainment of the human circadian clock. Cold Spring Harb Symp Quant Biol. 2007;72:293–9.
Roenneberg T, Kumar CJ, Merrow M. The human circadian clock entrains to sun time. Curr Biol. 2007;17(2):R44–R5.
Roenneberg T, Kuehnle T, Juda M, Kantermann T, Allebrandt K, Gordijn M, et al. Epidemiology of the human circadian clock. Sleep Med Rev. 2007;11(6):429–38.
Vetter C, Schernhammer ES. Early, but not late chronotypes, are up during their biological night when working the night shift. Occup Environ Med. 2015;72(3):235. doi:10.1136/oemed-2014-102572.
Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep. 2003;26(4):413–5.
Zhu Y, Brown HN, Zhang Y, Data L, Zheng T. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomark Prev. 2005;14(1):268–70.
Hansen J, Lassen CF. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med. 2012;69:551–6. doi:10.1136/oemed-2011-100240.
Harma M, Koskinen A, Ropponen A, Puttonen S, Karhula K, Vahtera J, et al. Validity of self-reported exposure to shift work. Occup Environ Med. 2016; doi:10.1136/oemed-2016-103902.
Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, et al. Night work and breast cancer—results from the German GENICA study. Scand J Work Environ Health. 2010;36(2):134–41. doi:2890 [pii]
Lie JA, Kjuus H, Zienolddiny S, Haugen A, Stevens RG, Kjaerheim K. Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics. Am J Epidemiol. 2011;173(11):1272–9. doi:10.1093/aje/kwr014.
Hansen J, Stevens RG. Night shiftwork and breast cancer risk: overall evidence. Occup Environ Med. 2011;68(3):236. doi:10.1136/oem.2010.061630.
Menegaux F, Truong T, Anger A, Cordina-Duverger E, Lamkarkach F, Arveux P, et al. Night work and breast cancer: a population-based case-control study in France (the CECILE study). Int J Cancer. 2013;132(4):924–31. doi:10.1002/ijc.27669.
Grundy A, Richardson H, Burstyn I, Lohrisch C, Sengupta SK, Lai AS, et al. Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med. 2013; doi:10.1136/oemed-2013-101482.
Fritschi L, Erren TC, Glass DC, Girschik J, Thomson AK, Saunders C, et al. The association between different night shiftwork factors and breast cancer: a case-control study. Br J Cancer. 2013;109(9):2472–80. doi:10.1038/bjc.2013.544.
Papantoniou K, Castano-Vinyals G, Espinosa A, Aragones N, Perez-Gomez B, Ardanaz E, et al. Breast cancer risk and night shift work in a case-control study in a Spanish population. Eur J Epidemiol. 2016;31(9):867–78. doi:10.1007/s10654-015-0073-y.
Wang P, Ren FM, Lin Y, Su FX, Jia WH, Su XF, et al. Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med. 2015;16(4):462–8. doi:10.1016/j.sleep.2014.11.017.
Li W, Ray RM, Thomas DB, Davis S, Yost M, Breslow N, et al. Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control. 2015;26(1):143–50. doi:10.1007/s10552-014-0493-0.
Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol. 2010;
Knutsson A, Alfredsson L, Karlsson B, Akerstedt T, Fransson EI, Westerholm P, et al. Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Scand J Work Environ Health. 2013;39(2):170–7. doi:10.5271/sjweh.3323.
Koppes LL, Geuskens GA, Pronk A, Vermeulen RC, de Vroome EM. Night work and breast cancer risk in a general population prospective cohort study in The Netherlands. Eur J Epidemiol. 2014;29(8):577–84. doi:10.1007/s10654-014-9938-8.
Akerstedt T, Knutsson A, Narusyte J, Svedberg P, Kecklund G, Alexanderson K. Night work and breast cancer in women: a Swedish cohort study. BMJ Open. 2015;5(4):e008127. doi:10.1136/bmjopen-2015-008127.
Travis RC, Balkwill A, Fensom GK, Appleby PN, Reeves GK, Wang XS, et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst. 2016;108(12) doi:10.1093/jnci/djw169.
Vistisen HT, Garde AH, Frydenberg M, Christiansen P, Hansen AM, Andersen J, et al. Short-term effects of night shift work on breast cancer risk: a cohort study of payroll data. Scand J Work Environ Health. 2017;43(1):59–67. doi:10.5271/sjweh.3603.
Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control. 1996;7(2):197–204.
Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12(1):74–7.
Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93(20):1557–62.
Lie JA, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control. 2006;17(1):39–44.
O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, et al. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol. 2006;164(4):358–66. doi:10.1093/aje/kwj211.
Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007;33(5):336–43. doi:1150 [pii]
•• Wegrzyn LR, Tamimi RM, Rosner BA, Brown SB, Stevens RG, Eliassen AH, et al. Rotating night shift work and risk of breast cancer in the Nurses’ Health studies. Am J Epidemiol. 2017; doi:10.1093/aje/kwx140. The best cohort-study, including long-term follow-up on rotating night shift-work and breast cancer
Applebaum KM, Malloy EJ, Eisen EA. Reducing healthy worker survivor bias by restricting date of hire in a cohort study of Vermont granite workers. Occup Environ Med. 2007;64(10):681–7. doi:10.1136/oem.2006.031369.
Applebaum KM, Malloy EJ, Eisen EA. Left truncation, susceptibility, and bias in occupational cohort studies. Epidemiology. 2011;22(4):599–606. doi:10.1097/EDE.0b013e31821d0879.
Schernhammer ES. RE: night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst. 2017;109(4) doi:10.1093/jnci/djx002.
Stevens RG. RE: night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst. 2017;109(4) doi:10.1093/jnci/djw342.
Hansen J. RE: night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst. 2017;109(4) doi:10.1093/jnci/djw344.
Stevens RG. Letter in reference to: “short-term effects of night shift work on breast cancer risk: a cohort study of payroll data”. Scand J Work Environ Health. 2017;43(1):95. doi:10.5271/sjweh.3607.
Ciarleglio CM, Ryckman KK, Servick SV, Hida A, Robbins S, Wells N, et al. Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythm. 2008;23(4):330–40. doi:10.1177/0748730408320284.
Bhatti P, Mirick DK, Davis S. Racial differences in the association between night shift work and melatonin levels among women. Am J Epidemiol. 2013;177(5):388–93. doi:10.1093/aje/kws278.
Papantoniou K, Castano-Vinyals G, Espinosa A, Aragones N, Perez-Gomez B, Ardanaz E, et al. Breast cancer risk and night shift work in a case-control study in a Spanish population. Eur J Epidemiol. 2015; doi:10.1007/s10654-015-0073-y.
Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer. 2012;48(11):1722–9. doi:10.1016/j.ejca.2011.07.005.
Surakasula A, Nagarjunapu GC, Raghavaiah KV. A comparative study of pre- and post-menopausal breast cancer: risk factors, presentation, characteristics and management. J Res Pharm Pract. 2014;3(1):12–8. doi:10.4103/2279-042X.132704.
Emilie Cordina-Duverger AP, Guenel P, Fritschi L, Glass D, Grundy A, Spinelli J, Aronson K, Rabstein S, Harth V, Pesch B, Brüning T, Castaño-Vinyals G, Kogevinas M. Night shift work and breast cancer risk: a combined analysis of population-based case-control studies with complete shift-work histories using a common definition of night work. Occup Environ Med. 2016;73(Supp1):1. doi:10.1136/oemed-2016-103951.619.
Papantoniou K, Kogevinas M. Shift work and breast cancer: do we need more evidence and what should this be? Occup Environ Med. 2013;70(12):825–6. doi:10.1136/oemed-2013-101630.
Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144(1):1–10. doi:10.1007/s10549-014-2852-7.
Lie JA, Kjuus H, Zienolddiny S, Haugen A, Kjaerheim K. Breast cancer among nurses: is the intensity of night work related to hormone receptor status? Am J Epidemiol. 2013;178(1):110–7. doi:10.1093/aje/kws428.
Cordina-Duverger E, Koudou Y, Truong T, Arveux P, Kerbrat P, Menegaux F, et al. Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: a population-based case-control study in France. Chronobiol Int. 2016:1–5. doi:10.3109/07420528.2016.1167709.
Rabstein S, Harth V, Pesch B, Pallapies D, Lotz A, Justenhoven C, et al. Night work and breast cancer estrogen receptor status—results from the German GENICA study. Scand J Work Environ Health. 2013;39(5):448–55. doi:10.5271/sjweh.3360.
Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res. 2010;12(6):R107. doi:10.1186/bcr2794.
Stevens RG, Hansen J, Schernhammer ES, Davis S, Response to Ijaz S, et al. Night-shift work and breast cancer--a systematic review and meta-analysis. Scand J Work Environ Health. 2013;39(6):631–2. doi:10.5271/sjweh.3385.
Lin X, Chen W, Wei F, Ying M, Wei W, Xie X. Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Med. 2015;16(11):1381–7. doi:10.1016/j.sleep.2015.02.543.
Jia Y, Lu Y, Wu K, Lin Q, Shen W, Zhu M, et al. Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol. 2013;37(3):197–206. doi:10.1016/j.canep.2013.01.005.
Kamdar BB, Tergas AI, Mateen FJ, Bhayani NH, Oh J. Night-shift work and risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138(1):291–301. doi:10.1007/s10549-013-2433-1.
Ijaz SI, Verbeek J, Seidler A, Lindbohm ML, Ojajarvi A, Orsini N, et al. Night-shift work and breast cancer—a systematic review and meta-analysis. Scand J Work Environ Health. 2013; doi:10.5271/sjweh.3371.
Merrow M, Boesl C, Ricken J, Messerschmitt M, Goedel M, Roenneberg T. Entrainment of the Neurospora circadian clock. Chronobiol Int. 2006;23(1–2):71–80.
Roenneberg T, Allebrandt KV, Merrow M, Vetter C. Social jetlag and obesity. Curr Biol. 2012;22(10):939–43. doi:10.1016/j.cub.2012.03.038.
• Van Dycke KC, Rodenburg W, van Oostrom CT, van Kerkhof LW, Pennings JL, Roenneberg T, et al. Chronically alternating light cycles increase breast cancer risk in mice. Curr Biol. 2015;25(14):1932–7. doi:10.1016/j.cub.2015.06.012. This is the most thorough study in order to demonstrate breast cancer risk in experimental animals after simulated shift-work
Chellappa SL, Gordijn MC, Cajochen C. Can light make us bright? Effects of light on cognition and sleep. Prog Brain Res. 2011;190:119–33. doi:10.1016/B978-0-444-53817-8.00007-4.
Nea FM, Kearney J, Livingstone MB, Pourshahidi LK, Corish CA. Dietary and lifestyle habits and the associated health risks in shift workers. Nutr Res Rev. 2015;28(2):143–66. doi:10.1017/S095442241500013X.
Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, et al. Meal frequency and timing in health and disease. Proc Natl Acad Sci U S A. 2014;111(47):16647–53. doi:10.1073/pnas.1413965111.
Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T, et al. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int. 2011;28(10):852–61. doi:10.3109/07420528.2011.618896.
Papantoniou K, Vetter C, Schernhammer ES. Shift work practices and opportunities for intervention. Occup Environ Med. 2017;74(1):2–3. doi:10.1136/oemed-2016-103904.
Bonde JP, Hansen J, Kolstad HA, Mikkelsen S, Olsen JH, Blask DE, et al. Work at night and breast cancer—report on evidence-based options for preventive actions. Scand J Work Environ Health. 2012;38(4):380–90. doi:10.5271/sjweh.3282.
Neil SE, Pahwa M, Demers PA, Gotay CC. Health-related interventions among night shift workers: a critical review of the literature. Scand J Work Environ Health. 2014; doi:10.5271/sjweh.3445.
Touitou Y, Reinberg A, Touitou D. Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: health impacts and mechanisms of circadian disruption. Life Sci. 2017; doi:10.1016/j.lfs.2017.02.008.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Johnni Hansen declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Occupational Health
Rights and permissions
About this article
Cite this article
Hansen, J. Night Shift Work and Risk of Breast Cancer. Curr Envir Health Rpt 4, 325–339 (2017). https://doi.org/10.1007/s40572-017-0155-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40572-017-0155-y